Check what the patient and team understood; never turn an unclear transcript into a treatment order.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Open the conversation
Greet the patient, offer a seat and ask how they are and which language they prefer. Establish symptoms or the reason for review with an open question before a targeted history of headache, diabetes, other illnesses and current medicines. Ask when tablets were started, not when the patient gives them. The table contains edited teaching examples, not authenticated quotations from a verified clinical recording. 1 2
Give information in manageable parts and ask the patient to explain the plan back in their own words. This checks the explanation rather than testing or blaming the patient. State what was agreed, what happens next, when it will be reviewed and whom to contact if symptoms change. 2 3
| Phase | Edited teaching example |
|---|---|
| Greeting | Hello. Please take a seat. How are you? |
| Wellbeing and language | How are you feeling? Which language do you prefer? |
| History | What illnesses and medicines do you have? Diabetes? When did you start the tablets? |
| Reason for visit | What brings you today? Any symptoms or planned review? Since when has the headache occurred? |
02Guide the examination
Use one instruction at a time: sit comfortably, place chin and forehead on the supports, look at the light or straight ahead, then up, down, right or left. Explain any discomfort and check that positioning is possible rather than demanding forceful contact. Ask the patient to open or close the eyes or close the left eye only when the test requires it. 1
For acuity, ask the patient to read the letters, numbers or last visible line. During refraction ask whether the image is clearer, less clear or unchanged; size and clarity are different questions. Allow uncertainty and avoid leading answers. Record what was measured, the correction used and whether a field was formal perimetry or only confrontation. 1
03Explain findings without guarantees
Dry eye can explain burning when supported by examination; saying it is only dryness and everything else is normal overstates an incomplete assessment. Lubricants may help, but the original 2–3 times daily and optional night use are examples, not a universal product schedule. Specify the selected preparation and individual instructions. 1
Describe cataract progression and discuss functional impact and options; not every cataract must be operated immediately. In usual surgery an opening is made in the anterior capsule and lens contents are removed, preserving posterior capsular support for an IOL when possible. Colours may appear different afterwards, but the garbled original colour dialogue cannot establish that every colour change is normal; pain or visual deterioration needs assessment. 1
Posterior capsule opacification (PCO, Nachstar) is clouding of the retained capsule after cataract surgery. A selected symptomatic case may benefit from Nd:YAG capsulotomy, which opens that membrane; explain benefits and risks rather than calling it completely harmless. The original analogy heading has no actual explanatory analogy underneath, so no missing analogy is presented as an authenticated source example. 1 4
The original pressures right 13 and left 15 mmHg are an example, not automatically good for every glaucoma stage. Its 12–20 mmHg normal range is not an individual target or a rule excluding glaucoma. Ask about drop use, technique, side effects and barriers; explain risk of progression without the threat that every missed treatment inevitably causes blindness. 1 5
Reactivated ocular toxoplasmosis may involve retinitis, oedema and adjacent gliosis near the disc; distinguish active infection from residual scar. Explain why specialist-selected anti-infective treatment or, in selected cases, intravitreal therapy is being considered rather than promising a generic antibiotic or injection for every oedema. Positive statements about vessels, macula, cornea or anterior segment apply to the examined structures and test limits, not to every possible disease. 1
04Medicines, dilation and follow-up
Read back the exact medicine name, concentration, eye, dose, frequency and duration. The original unclear Hylodoze wording, 3 times daily before 4 weeks and 3% once daily before 3 weeks must remain unresolved transcript fragments, not guessed prescriptions. Check the intended order with the responsible clinician before administration and ask the patient to demonstrate drop technique. 1 2 3
Explain that dilating drops can blur vision and increase glare. Arrange transport or an accompanying person and do not drive while vision remains affected; the garbled original 4–5 hours does not certify safe driving afterwards. Discuss distance/near spectacles, bifocal or progressive options according to needs. Follow-up in 6 months, 1 year or 4 weeks are original examples and must be selected for the actual disease and risk, not used as a universal schedule. 1 6
05Close the loop within the team
Name the requested test, eye, reason, responsible person and review plan. Diabetes review and a previous February assessment are workflow examples; clarify what records are relevant before copying, scanning or stamping. Confirm appointments and responsibility for reviewing results. A confrontation field recorded as normal is not equivalent to a normal automated field. 1 3
For peripheral findings at 8–9 o’clock, specify the eye and orientation. The old-foramen phrase with aufgeregelt mit Leder is uninterpretable and must not be silently rewritten as laser treatment. Document no new hole only within the examined extent; clarify a slightly loosened macula with the examination and selected OCT, and describe vascular tortuosity without inferring a cause. 1
Cornea clear, mild cataract and sharp disc margins describe separate structures. The original CDR 09 is ambiguous: do not automatically convert it to 0.9. If a measured cup-to-disc ratio is confirmed, record it explicitly with disc size, rim, asymmetry and supporting tests; pressure or a ratio alone does not diagnose glaucoma. 1
| Term | Contextual explanation |
|---|---|
| Cataract | Clouding of the lens |
| Sicca syndrome | Dry eye symptoms and signs |
| PCO/Nachstar | Opacification of retained posterior capsule after cataract surgery |
| Glaucoma | Optic neuropathy often associated with raised pressure |
| Oedema | Fluid accumulation in tissue, for example macula |
| Gliosis | Glial response/scarring, here in retina |
| Toxoplasmosis | Infection that can cause retinochoroiditis |
| IOL | Artificial intraocular lens |
| Intravitreal administration | Injection into the vitreous cavity |
| Visual acuity | Ability to resolve detail under specified test conditions |
| Refraction | Assessment of optical error for correction |
| CDR | Cup-to-disc ratio interpreted with disc size and rim |
| Foramen | Hole, here in the retina |
| Tortuosity | Vessel winding, a description rather than a cause |
What are the main learning points?
Check what the patient and team understood; never turn an unclear transcript into a treatment order.
When is assessment urgent?
Sudden visual loss, increasing pain, marked redness or new neurological symptoms needs urgent assessment; clarify an unclear drug order before using it.
References and access status
- 1Immutable original export; unidentified dialogue/teaching source; authenticity not verified
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 2NICE NG197: shared decision making recommendations
Selected official guidance text read on 2026-11-09; complete document and supplements not read.
- 3WHO: communication during patient handovers
Selected official guidance text read on 2026-11-09; complete document and supplements not read.
- 4AAO: posterior capsulotomy and patient risk information
Selected official guidance text read on 2026-11-09; complete document and supplements not read.
- 5EGS: target IOP treatment principles, historical fourth edition
Selected official guidance text read on 2026-11-09; complete document and supplements not read.
- 6UK diabetic eye screening: people who drive, updated 2024
Selected official guidance text read on 2026-11-09; complete document and supplements not read.
For patients
Ask about your findings, options and next appointment. Repeat the agreed drop name, eye, dose and duration in your own words so that misunderstandings can be corrected.
Examination and selected tests guide individual treatment and follow-up; this educational text cannot replace your own assessment.
Sudden visual loss, increasing pain, marked redness or new neurological symptoms needs urgent assessment; clarify an unclear drug order before using it.
Sudden visual loss, increasing pain, marked redness or new neurological symptoms needs urgent assessment; clarify an unclear drug order before using it.